Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Lung cancer and precision medicine

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 21.02.18
Views: 613
Rating:

Dr Pilar Garrido - Universidad de Alcalá, Madrid, Spain

Dr Pilar Garrido presents at ecancer's Milan Summit on Precision Medicine 2018 about the current situation regarding lung cancer and precision medicine.

She outlines some of the genomic targets for lung cancer, including immunotherapy biomarkers.

Dr Garrido also gives her thoughts on the challenges when using NGS.

The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine

Related videos

follow us

Siyemi immunocology e-learning


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation